Trial · NCT03386344
Results by group27
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 27
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Hemoglobin A1c (HbA1c) at Week 26 | Placebo | -0.22 | Standard Error 0.080 | percentage of HbA1c | |
| Change From Baseline in Hemoglobin A1c (HbA1c) at Week 26 | Sotagliflozin 200 mg | -0.66 | Standard Error 0.077 | percentage of HbA1c | |
| Change From Baseline in Hemoglobin A1c (HbA1c) at Week 26 | Sotagliflozin 400 mg | -0.67 | Standard Error 0.079 | percentage of HbA1c | |
| Percent Change From Baseline in Bone Mineral Density (BMD) of Lumbar Spine at Week 26 | Placebo | 0.37 | Standard Error 0.327 | percent change | |
| Percent Change From Baseline in Bone Mineral Density (BMD) of Lumbar Spine at Week 26 | Sotagliflozin 200 mg | 0.13 | Standard Error 0.323 | percent change | |
| Percent Change From Baseline in Bone Mineral Density (BMD) of Lumbar Spine at Week 26 | Sotagliflozin 400 mg | 0.22 | Standard Error 0.327 | percent change | |
| Percent Change From Baseline in Bone Mineral Density (BMD) of Total Hip at Week 26 | Placebo | -0.36 | Standard Error 0.259 | percent change | |
| Percent Change From Baseline in Bone Mineral Density (BMD) of Total Hip at Week 26 | Sotagliflozin 200 mg | -0.22 | Standard Error 0.220 | percent change | |
| Percent Change From Baseline in Bone Mineral Density (BMD) of Total Hip at Week 26 | Sotagliflozin 400 mg | -0.16 | Standard Error 0.223 | percent change | |
| Percent Change From Baseline in Bone Mineral Density (BMD) of Femoral Neck at Week 26 | Placebo | -0.94 | Standard Error 0.379 | percent change | |
| Percent Change From Baseline in Bone Mineral Density (BMD) of Femoral Neck at Week 26 | Sotagliflozin 200 mg | -0.20 | Standard Error 0.332 | percent change | |
| Percent Change From Baseline in Bone Mineral Density (BMD) of Femoral Neck at Week 26 | Sotagliflozin 400 mg | -0.62 | Standard Error 0.338 | percent change | |
| Change From Baseline in Body Weight at Week 26 | Placebo | -0.46 | Standard Error 0.261 | kilogram (kg) | |
| Change From Baseline in Body Weight at Week 26 | Sotagliflozin 200 mg | -2.37 | Standard Error 0.258 | kilogram (kg) | |
| Change From Baseline in Body Weight at Week 26 | Sotagliflozin 400 mg | -2.16 | Standard Error 0.264 | kilogram (kg) | |
| Change From Baseline in Fasting Plasma Glucose (FPG) at Week 26 | Placebo | -7.274 | Standard Error 3.6064 | milligram per deciliter (mg/dL) | |
| Change From Baseline in Fasting Plasma Glucose (FPG) at Week 26 | Sotagliflozin 200 mg | -26.165 | Standard Error 3.4656 | milligram per deciliter (mg/dL) | |
| Change From Baseline in Fasting Plasma Glucose (FPG) at Week 26 | Sotagliflozin 400 mg | -28.607 | Standard Error 3.5912 | milligram per deciliter (mg/dL) | |
| Change From Baseline in Systolic Blood Pressure (SBP) at Week 12 | Placebo | -0.80 | Standard Error 1.149 | millimeter of mercury (mmHg) | |
| Change From Baseline in Systolic Blood Pressure (SBP) at Week 12 | Sotagliflozin 200 mg | -1.61 | Standard Error 1.130 | millimeter of mercury (mmHg) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03386344/results